Betul Hatipoglu, MD
- Specialty: Endocrinology
-
Primary Location: 11100 Euclid Ave (0 mi.)
Other Locations - Languages Spoken: English
Office Locations
UH Cleveland Medical Center Mather (0 mi.)
11100 Euclid Ave
Mather Ste 1600
Cleveland, OH 44106
216-844-3142
UH Minoff Health Center (7 mi.)
3909 Orange Pl
Ste 3100
Beachwood, OH 44122
216-844-3142
University Hospitals (7 mi.)
5885 Landerbrook Dr
Ste 100
Mayfield Heights, OH 44124
216-286-8988
Biography: Betul Hatipoglu, MD
Titles
- Director, Diabetes Center, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
- Mary B. Lee Chair in Adult Endocrinology, University Hospitals
Certifications & Memberships
- Endocrinology, Diabetes and Metabolism - American Board of Internal Medicine
Education
Fellowship | Endocrinology
Endocrinology - University Of Illinois At Chicago Medical Center (1997 - 1999)
Residency | Internal Medicine/Chief Resident
Internal Medicine/Chief Resident - Michael Reese Hospital And Medical Center (1996 - 1997)
Residency | Internal Medicine
Internal Medicine - Michael Reese Hospital And Medical Center (1993 - 1996)
Medical Education
Istanbul University School Of Medicine (1992)
About
Betul Hatipoglu, MD, is the Medical Director of the Diabetes & Metabolic Care Center, and the Mary B. Lee Chair in Adult Endocrinology at University Hospitals Cleveland Medical Center since 2020. She is also a Professor of Medicine at Case Western Reserve University School of Medicine and Vice Chair at UH System Clinical Affairs.
Prior to her appointment at University Hospitals, she was a staff endocrinologist at the Cleveland Clinic for over 10 years. Dr. Hatipoglu was an Assistant Professor of Medicine and the Medical Director for the Pancreas and Islet Cell Transplant Program at the University of Illinois at Chicago for nearly eight years prior. Her clinical interests include cardiovascular disease in diabetes and population health. She received numerous excellence in teaching awards from different institutions and mentorship awards. Her research interests are in autologous islet cell transplant in chronic pancreatitis patients and new treatment modalities in type 1 diabetes and management of diabetes in population health.
Research & Publications
Research Links
PubMed
View Research
Research Interests
autologous islet cell transplant in chronic pancreatitis patients | new treatment modalities in type 1 diabetes | management of diabetes in population health
Featured Videos
Patient Experience Reviews
This has been and is still a great team!
Excellent physician
Wonderful doctor!
The The finest, old-fashioned, personal professional attention, concern and care. Extremely thorough, patient and a great listener as well as explainer.
The doctor Is the best provider I have for my medical care. I would HIGHLY RECOMMEND her. She Is truly concerned about you, your care and is so knowledgeable. She is an asset to your hospital system, as well as my endocrinology management.
Dr Hatipoglu is excellent and is very caring and thorough.
Dr. Hatipoglu is the best doctor I've ever had. She is the perfect example of the best care and human connection in the medical field. Her staff goes above and beyond to make patients feel comfortable, welcome and safe. Dr. Hatipoglu takes all your concerns seriously and is exceptionally thorough with the care she provides. I wish all doctors were like her and she should be the gold standard for the medical field.
SUPER visit with Dr. Hatipoglu.
Love my doctor.
Dr. Hatipoglu is an exceptional doctor. She has superior knowledge, significant experience with excellent practical application of both. She is a true credit to UH, her profession and her patients. I followed Dr. Hatipoglu to UH from the ***.
Dr Hatipoglu is exceptional!
Dr. Hatipoglu is one of the most personable, understanding and compassionate doctors I have ever met. My team of providers are all at ***, I had her as my endocrinologist at *** prior to joining University Hospitals. I would follow her anywhere that she was practicing
Very positive experience
Dr. Hatipoglu is a gift to medicine. I wish we could clone her and put her into every specialty. I don't know how I got so lucky to have her as my provider. She had a fellow with her as well during my visit, and he has a bright future. He was kind and thorough and I am so glad Dr. Hatipoglu is training future providers.
Love Dr. Hati
Dr. Hatipoglu and her staff are excellent. I followed her from *** because of her care and concern for her patients. ***
Related Blog Articles
2 Local ‘Diabetes Warriors’ Separated by 86 Years
Bonding over their shared type 1 diabetes diagnosis, 90-year-old Don and 4-year-old Teddy became fast friends after meeting at a UH diabetes event.
Coordinated Care Helps Woman Conquer Multiple Health Challenges
Susan Welch has faced more than her fair share of health challenges over the years. Through it all, her endocrinologist, Betul Hatipoglu, MD, was by her side to support, encourage and offer innovative options for treatment.
Newly Diagnosed With Diabetes? Here’s What to Expect
If patients educate themselves, they can manage the disease and live healthier lives. Some can even reverse the disease.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Betul Hatipoglu did not disclose any Outside Relationships with Industry.